Location: Home >> News >> All News >> Health >> Content

Roche's breast cancer drug gets FDA nod

2012-6-11 10:26 

(Reuters) - U.S. health regulators have approved a new breast cancer drug from Roche Holding AG that the company hopes will become the standard treatment for women with an aggressive, incurable form of cancer. Roche unit Genentech announced Friday that the Food and Drug Administration approved the injectable drug Perjeta for women with a type of breast cancer known as HER-2 positive, which makes up about a quarter of all breast cancers and has no cure. Analysts predict the medicine could be another blockbuster cancer drug for the Swiss company.

By Anna Yukhananov
Fri Jun 8, 2012 9:23pm EDT

 

 

Click here to read the whole story

Return to GoPath by clicking back arrow on the webpage

Print    Close
Prev Next
Related:
 

Rating:0

Comments
seccode Change another
View all reply【0 users already expressed their views】
Commend news
Latest news